Results 211 to 220 of about 64,926 (256)
Some of the next articles are maybe not open access.
Metabolism and functions of neuropeptide Y
Neurochemical Research, 1996Neuropeptide Y is one of the most abundant neuropeptides in the central and peripheral nervous systems and its sequence is highly conserved among species. A number of key physiological roles for NPY are now emerging, especially in the control of feeding and energy homeostasis. Other physiological actions of NPY are also reviewed.
M dos S, Medeiros, A J, Turner
openaire +2 more sources
Introduction to the reviews on neuropeptide Y
Neuropeptides, 2004Neuropeptide Y (NPY) was first reported as an abundant peptide in brain tissue in 1982. Shortly thereafter, NPY was found to be a member of a peptide family consisting of the endocrine peptides pancreatic polypeptide (PP) and peptide YY (PYY). These peptides exert most of their biological effects through five G-protein coupled receptors termed Y1, Y2 ...
openaire +2 more sources
Neuropeptide Y in the dentate gyrus
2007Neuropeptide Y (NPY) is contained in at least four types of GABAergic interneurons in the dentate gyrus, many of which also contain somatostatin and give rise to the dense NPY innervation of the dentate outer molecular layer. In humans but not rats, minute amounts of NPY are also normally expressed in dentate granule cells, while seizure activity in ...
Günther, Sperk +2 more
openaire +2 more sources
American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2002
openaire +4 more sources
openaire +4 more sources
Nihon rinsho. Japanese journal of clinical medicine, 2000
Y, Kawakami, T, Nakai
openaire +3 more sources
Y, Kawakami, T, Nakai
openaire +3 more sources
Neuropeptide Y has a stimulatory action on feeding behavior in goldfish (Carassius auratus)
European Journal of Pharmacology, 1999Marcos A López-Patiño +2 more
exaly
Neuropeptide Y effector systems: perspectives for drug development
Trends in Pharmacological Sciences, 1994Rolf Håkanson, Lars Grundemar
exaly